Business

USFDA for voluntary action by Sun Pharma on Dadra plant observations

USFDA for voluntary action by Sun Pharma on Dadra plant observations The health regulator had inspected the company#39;s Dadra facility from March 22 - March 29, 2019; and at the conclusion of the inspection, had issued a Form 483, with 11 observations to the company.

from Moneycontrol Business News
Read The Rest:moneycontrol...

Realted Posts